Organization
Rijnstate Hospital
4 clinical trials
2 abstracts
Abstract
Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).Org: The Netherlands Cancer Institute, Erasmus MC Cancer Institute, Netherlands Comprehensive Cancer Organisation (IKNL), Erasmus School of Health Policy & Management, Spaarne Gasthuis,
Clinical trial
Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid NodulesStatus: Recruiting, Estimated PCD: 2027-12-01
Clinical trial
Multicentre Randomized Trial of Ghrelin in Anterior Circulation Ischemic Stroke Treated With Endovascular Thrombectomy. A Randomized Phase 2 TrialStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
DUTCH Weight Control in Atrial Fibrillation Study, a Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-05-01
Clinical trial
StudY of Effect of Nimodipine and Acetaminophen on Postictal Symptoms After ECTStatus: Completed, Estimated PCD: 2022-12-30
Abstract
High dose alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Results from the randomized phase 3 OLIGO study.Org: The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Rijnstate Hospital, Ziekenhuis ZGT Hengelo, Amphia Hospital,